Phase II Trial of Immunonutrition in Hepatectomy
Recruiting
N/A
Interventional Study
Hepatocellular Carcinoma
ASA I-III Patients
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 90
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 100 (estimated)
- Sponsor
- Tata Memorial Centre · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
A randomised open labelled study to evalaute the impact of immunonutrition in Patients Undergoing Hepatectomies for Liver Tumors
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Patients with liver tumors planned for major hepatectomies (defined as resection of \>/= 3 liver segments)
2. Age above 18 years
3. ASA class I-III
Exclusion Criteria:
1. Preoperative severe renal failure (estimated glomerular filtration rate \< 30 ml/min)
2. History of hyp…
Contacts